StockData
PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31

PURE BIOSCIENCE, INC.

Financials through Q3 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Jun 15, 2026
$0.07−0.01 (-12.10%)

Close on Oct 19, 2026

Market cap
$7.33M
P/E (TTM)
–
Dividend yield
–

PURE BIOSCIENCE, INC. revenue by segment

By business segment

By product or service

RevenueQ3 26Q2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23% of revenueYoY
Product [Member]$506.00K$443.00K$707.00K$763.00K$489.00K$391.00K$555.00K$472.00K$440.00K$325.00K$718.00K$602.00K100.0%+3.5%
SILVERION [Member]$414.00K$14.00K–$10.00K$21.00K$7.00K$166.00K$0$90.00K––$081.8%+1871.4%
PURE Hard Surface [Member]$92.00K$429.00K$707.00K$753.00K$468.00K$384.00K$389.00K$472.00K$350.00K$325.00K$718.00K$602.00K18.2%-80.3%
Royalty [Member]$0$1.00K$1.00K$1.00K$2.00K$0$1.00K$2.00K$1.00K$1.00K$4.00K$00.0%-100.0%

By region

From the segment and revenue-disaggregation notes of Pure Bioscience's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.